1例急性B淋巴细胞白血病伴耐碳青霉烯解鸟氨酸拉乌尔菌败血症的治疗并文献复习
Treatment and Literature Review of One Case of Acute B Lymphoblastic Leukemia with Carbapenem-Resistant Raoultella ornithinolytica Sepsis
DOI: 10.12677/ACM.2022.1291232, PDF,   
作者: 张潇玉, 许 晗：青岛大学医学部，山东 青岛；青岛大学附属医院血液科，山东 青岛；徐玉洁, 冯献启*：青岛大学附属医院血液科，山东 青岛
关键词: 急性B淋巴细胞白血病；头孢他啶/阿维巴坦；解鸟氨酸拉乌尔菌；病例报告；Acute B Lymphoblastic Leukemia； Ceftazidime/Avibactam； Raoultella ornithinolytica； Case Report
摘要: 目的：探讨急性白血病伴解鸟氨酸拉乌尔菌败血症的临床特点、诊断及治疗，提高对该细菌的认识。方法：回顾1例急性B淋巴细胞白血病(B-ALL)伴耐碳青霉烯解鸟氨酸拉乌尔菌感染病人的临床资料，分析其临床特点并复习相关文献。结果：结合患者的临床资料及辅助检查，诊断为B-ALL化疗后伴耐碳青霉烯的解鸟氨酸拉乌尔菌败血症，给予以头孢他啶/阿维巴坦(CAZ/AVI)为主的联合抗感染、促造血、输血、保肝等治疗，患者病情好转。结论：以CAZ/AVI为主的联合方案可能是治疗耐碳青霉烯的解鸟氨酸拉乌尔菌引起的血液感染和皮肤感染的有效选择。
Abstract: Objective: To investigate the clinical features, diagnosis and treatment of acute leukemia with Ra-oultella ornithinolytica sepsis, and to improve the understanding of this bacterium. Methods: To re-view the clinical data of a case of acute B-lymphoblastic leukemia (B-ALL) with carbapenem- re-sistant Raoultella ornithinolytica infection, analyze its clinical characteristics and review the rele-vant literature. Results: Combined with the patient’s clinical data and auxiliary examination, the patient was diagnosed as B-ALL chemotherapy with carbapenem-resistant Raoultella ornithinolyti-ca sepsis. The patient was given ceftazidime/avibactam (CAZ/AVI) combined with anti-infection, hematopoietic promotion, blood transfusion, liver protection and other treatments, and the pa-tient’s condition improved. Conclusion: CAZ/AVI based combination regimen may be an effective choice for the treatment of blood and skin infections caused by carbapenem-resistant Raoultella or-nithinolytica.
文章引用：张潇玉, 许晗, 徐玉洁, 冯献启. 1例急性B淋巴细胞白血病伴耐碳青霉烯解鸟氨酸拉乌尔菌败血症的治疗并文献复习[J]. 临床医学进展, 2022, 12(9): 8536-8541. https://doi.org/10.12677/ACM.2022.1291232

参考文献

[1] Drancourt, M., Bollet, C., Carta, A. and Rousselier, P. (2001) Phylogenetic Analyses of Klebsiella Species Delineate Klebsiella and Raoultella gen. nov., with Description of Raoultella ornithinolytica comb. nov., Raoultella terrigena comb. nov. and Raoultella planticola comb. nov. The International Journal of Systematic and Evolutionary Microbiology, 51, 925-932. [Google Scholar] [CrossRef] [PubMed]
[2] Abbas, A. and Ahmad, I. (2018) First Report of Neo-natal Early-Onset Sepsis Caused by Multi-Drug-Resistant Raoultella ornithinolytica. Infection, 46, 275-277. [Google Scholar] [CrossRef] [PubMed]
[3] Sekowska, A. (2017) Raoultella spp.-Clinical Significance, Infec-tions and Susceptibility to Antibiotics. Folia Microbiologica (Praha), 62, 221-227. [Google Scholar] [CrossRef] [PubMed]
[4] De Petris, L. and Ruffini, E. (2018) Roultella ornithinolytica In-fection in Infancy: A Case of Febrile Urinary Tract Infection. CEN Case Reports, 7, 234-236. [Google Scholar] [CrossRef] [PubMed]
[5] Alsharawneh, A. (2021) Effect of Undertriage on the Outcomes of Cancer Patients with Febrile Neutropenia, Sepsis, and Septic Shock. Clinical Nursing Research, 30, 1127-1134. [Google Scholar] [CrossRef] [PubMed]
[6] Giske, C.G., Monnet, D.L., Cars, O. and Carmeli, Y. (2008) Clinical and Economic Impact of Common Multidrug- Resistant Gram-Negative Bacilli. Antimicrobial Agents and Chem-otherapy, 52, 813-821. [Google Scholar] [CrossRef] 
[7] Huang, A.H., Liu, Y., Hsien, Y.C., et al. (2021) Survival Impact and Clinical Predictors of Acute Gastrointestinal Bleeding in Patients with Bloodstream Infection. Journal of Intensive Care Medicine, 36, 63-69. [Google Scholar] [CrossRef] [PubMed]
[8] Sung, L., Gamis, A., Alonzo, T.A., et al. (2009) Infections and Association with Different Intensity of Chemotherapy in Children with Acute Myeloid Leukemia. Cancer, 115, 1100-1108. [Google Scholar] [CrossRef] [PubMed]
[9] Morais, V.P., Daporta, M.T., Bao, A.F., Campello, M.G. and Andres, G.Q. (2009) Enteric Fever-Like Syndrome Caused by Raoultella ornithinolytica (Klebsiella ornithinolytica). Journal of Clinical Microbiology, 47, 868-869. [Google Scholar] [CrossRef] 
[10] Seng, P., Boushab, B.M., Romain, F., et al. (2016) Emerging Role of Raoultella ornithinolytica in Human Infections: A Series of Cases and Review of the Literature. International Journal of Infectious Diseases, 45, 65-71. [Google Scholar] [CrossRef] [PubMed]
[11] Cleveland, K.O., Mazumder, S.A. and Gelfand, M.S. (2014) Asso-ciation of Raoultella bacteremia with Diseases of the Biliary Tract. Scandinavian Journal of Infectious Diseases, 46, 541-542. [Google Scholar] [CrossRef] [PubMed]
[12] Chun, S., Yun, J.W., Huh, H.J. and Lee, N.Y. (2015) Clinical Characteristics of Raoultella ornithinolytica Bacteremia. Infection, 43, 59-64. [Google Scholar] [CrossRef] [PubMed]
[13] 古达清. 解鸟氨酸克雷伯菌与医院感染的关系[J]. 中国医药指南, 2010, 8(31): 52-53. [Google Scholar] [CrossRef] 
[14] Ehmann, D.E., Jahic, H., Ross, P.L., Gu, R.F., Hu, J., Du-rand-Réville, T.F., Lahiri, S., Thresher, J., Livchak, S., Gao, N., Palmer, T., Walkup, G.K. and Fisher, S.L. (2013) Ki-netics of Avibactam Inhibition against Class A, C, and D β-Lactamases. Journal of Biological Chemistry, 288, 27960-27971. [Google Scholar] [CrossRef] 
[15] Zhang, P., Shi, Q., Hu, H., et al. (2020) Emergence of Ceftazidime/Avibactam Resistance in Carbapenem-Resistant Klebsiella pneumoniae in China. Clinical Microbiology and Infection, 26, 121-124. [Google Scholar] [CrossRef] [PubMed]
[16] Castón, J.J., Lacort-Peralta, I., Martín-Dávila, P., Loeches, B., Tabares, S., Temkin, L., Torre-Cisneros, J. and Paño- Pardo, J.R. (2017) Clinical Efficacy of Ceftazidime/Avibactam versus Other Active Agents for the Treatment of Bacteremia Due to Carbapenemase-Producing Enterobacteriaceae in Hematologic Patients. International Journal of Infectious Diseases, 59, 118-123. [Google Scholar] [CrossRef] [PubMed]

为你推荐